Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 588-591

  Katragkou, Aspasia ^a   Chatzimoschou, Athanasios ^a   Simitsopoulou, Maria ^a   Georgiadou, Elpiniki ^a   Roilides, Emmanuel ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antifungal agents; Azoles; Caspofungin; Echinocandins; Host defences

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL)2H TETRAZOLIUM 5 CARBOXANILIDE; ANIDULAFUNGIN; ANILIDE; CASPOFUNGIN; POSACONAZOLE; SILASTIC; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA PARAPSILOSIS; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PLANKTON;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; ECHINOCANDINS; HUMANS; MICROBIAL VIABILITY; MONOCYTES; NEUTROPHILS; STAINING AND LABELING; TETRAZOLIUM SALTS; TRIAZOLES;

EID: 79951526042     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq466     Document Type: Article

References (12)

1. Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21: 606-25.
2. Almirante B, Rodriguez D, Cuenca-Estrella M et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006; 44: 1681-5.
3. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-6.
4. Roilides E, Walsh T. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Med Mycol 2004; 42: 1-13.
5. Ramage G, Vande Walle K, Wickes BL et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-9.
6. Kuhn DM, Chandra J, Mukherjee PK et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002; 70: 878-88.
7. Katragkou A, Kruhlak MJ, Simitsopoulou M et al. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis 2010; 201: 1941-9.
8. Vora S, Purimetla N, Brummer E et al. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrob Agents Chemother 1998; 42: 907-10.
9. Bochud PY, Chien JW, Marr KA et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008; 359: 1766-77.
10. Fleischhacker M, Radecke C, Schulz B et al. Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. Eur J Clin Microbiol Infect Dis 2008; 27: 127-31.
11. van Asbeck EC, Hoepelman AI, Scharringa J et al. The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. Int J Antimicrob Agents 2009; 33: 21-6.
12. Gow NA, Netea MG, Munro CA et al. Immune recognition of Candida albicans β-glucan by dectin-1. J Infect Dis 2007; 196: 1565-71.